Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Daisuke Kajiwara
Observed name:
D. Kajiwara
Institution:
Taiho Pharmaceutical (Japan)
Observed institutions:
Gifu Pharmaceutical University,
Hôpital Notre-Dame,
Taiho Pharmaceutical (Japan),
Centre Hospitalier de l’Université de Montréal,
Gifu University,
Université de Montréal,
The University of Tokyo
show all 7
OpenAlex ID:
A5002498835
Role of Interleukin-5 and Eosinophils in Allergen-Induced Airway Remodeling in Mice
2004
·
Hiroyuki Tanaka
, Masato Komai
, et al.
·
American Journal of Respiratory Cell and Molecular Biology
·
179
Mast cells play a partial role in allergen‐induced subepithelial fibrosis in a murine model of allergic asthma
2003
·
T. Masuda
, H. Tanaka
, et al.
·
Clinical & Experimental Allergy
·
63
Nafamostat Mesilate, a Potent Serine Protease Inhibitor, Inhibits Airway Eosinophilic Inflammation and Airway Epithelial Remodeling in a Murine Model of Allergic Asthma
2008
·
Masayuki Ishizaki
, Hiroyuki Tanaka
, et al.
·
Journal of Pharmacological Sciences
·
34
PDF
A Novel CC-Chemokine Receptor 3 Antagonist, Ki19003, Inhibits Airway Eosinophilia and Subepithelial/Peribronchial Fibrosis Induced by Repeated Antigen Challenge in Mice
2010
·
Masato Komai
, Hiroyuki Tanaka
, et al.
·
Journal of Pharmacological Sciences
·
30
PDF
Role of hematopoietic prostaglandin D synthase in biphasic nasal obstruction in guinea pig model of experimental allergic rhinitis
2011
·
Daisuke Kajiwara
, Hiroki Aoyagi
, et al.
·
European Journal of Pharmacology
·
16
Experimentally Induced Eosinophilic Polyps in Rabbit Sinuses
2010
·
Takayuki Sejima
, Daisuke Kajiwara
, et al.
·
American Journal of Rhinology and Allergy
·
10
TAS 3681, an androgen receptor antagonist, prevents drug resistance driven by aberrant androgen receptor signaling in prostate cancer
2024
·
Shohei Yoshida
, Daisuke Kajiwara
, et al.
·
Molecular Oncology
·
9
Novel Bruton’s tyrosine kinase inhibitor TAS5315 suppresses the progression of inflammation and joint destruction in rodent collagen-induced arthritis
2023
·
Daichi Akasaka
, Satoru Iguchi
, et al.
·
PLoS ONE
·
7
PDF
Potential synergistic effects of novel hematopoietic prostaglandin D synthase inhibitor TAS-205 and different types of anti-allergic medicine on nasal obstruction in a Guinea pig model of experimental allergic rhinitis
2020
·
Hiroki Aoyagi
, Daisuke Kajiwara
, et al.
·
European Journal of Pharmacology
·
6
Effect of a new type androgen receptor antagonist, TAS3681, on ligand-independent AR activation through its AR downregulation activity.
2016
·
Daisuke Kajiwara
, Kazuhisa Minamiguchi
, et al.
·
Journal of Clinical Oncology
·
6
TAS3681, a novel type of AR antagonist with AR downregulating activity, as a new targeted therapy for aberrant AR-driven prostate cancer.
2018
·
Masanao Seki
, Kazuhisa Minamiguchi
, et al.
·
Journal of Clinical Oncology
·
5
Analysis of novel enzalutamide-resistant cells: upregulation of testis-specific Y-encoded protein gene promotes the expression of androgen receptor splicing variant 7
2020
·
Masanao Seki
, Daisuke Kajiwara
, et al.
·
Translational Cancer Research
·
4
PDF
The impact of TAS3681, a new type of androgen receptor antagonist, on aberrant AR signaling that drives tumor resistance to AR-targeted therapies by down-regulating full length and splice variant AR.
2017
·
Daisuke Kajiwara
, Kazuhisa Minamiguchi
, et al.
·
Journal of Clinical Oncology
·
4
TAS3681: New class of androgen receptor antagonist with androgen receptor downregulating activity.
2015
·
Kazuhisa Minamiguchi
, Masanao Seki
, et al.
·
Journal of Clinical Oncology
·
3
Bruton's Tyrosine Kinase Inhibitor Tas5315, as a Potential Therapeutic Agent Against Chronic Spontaneous Urticaria
2024
·
D. Kajiwara
, D. Akasaka
, et al.
·
Annals of Allergy Asthma & Immunology
·
1
TAS3681, a new type of androgen receptor antagonist, disrupts aberrant AR signaling that drives tumor resistance to AR-targeted therapies by downregulating full-length and splice variant AR
2016
·
D. Kajiwara
, K. Minamiguchi
, et al.
·
European Journal of Cancer
·
1
Abstract PR09: TAS3681, a new type androgen receptor antagonist, suppresses ligand-independent AR activation through its AR downregulation activity
2015
·
Daisuke Kajiwara
, Kazuhisa Minamiguchi
, et al.
·
Molecular Cancer Therapeutics
·
1
Author response for " TAS 3681, an androgen receptor antagonist, prevents drug resistance driven by aberrant androgen receptor signaling in prostate cancer"
2024
·
Shohei Yoshida
, Daisuke Kajiwara
, et al.
·
Publons reviews and discussion
315 Biological characterization of TAS3681, a new type of androgen receptor antagonist with androgen receptor downregulating activity
2014
·
K. Minamiguchi
, M. Seki
, et al.
·
European Journal of Cancer
Hematopoietic Prostaglandin D Synthase Is a Useful Target For Treating Nasal Obstruction In Guinea Pigs With Allergic Rhinitis
2014
·
Daisuke Kajiwara
, Hiroki Aoyagi
, et al.
·
Journal of Allergy and Clinical Immunology
Show more works
View as search
Works count:
20
Citation count:
379
H-index:
7
I10-index:
6
Year
Topic
Type